199 related articles for article (PubMed ID: 24051307)
1. A single extra copy of Dscr1 improves survival of mice developing spontaneous lung tumors through suppression of tumor angiogenesis.
Shin J; Lee JC; Baek KH
Cancer Lett; 2014 Jan; 342(1):70-81. PubMed ID: 24051307
[TBL] [Abstract][Full Text] [Related]
2. Trisomy of the Dscr1 gene suppresses early progression of pancreatic intraepithelial neoplasia driven by oncogenic Kras.
Lee JC; Shin J; Baek KH
Biochem Biophys Res Commun; 2013 Oct; 440(1):50-5. PubMed ID: 24041692
[TBL] [Abstract][Full Text] [Related]
3. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1.
Baek KH; Zaslavsky A; Lynch RC; Britt C; Okada Y; Siarey RJ; Lensch MW; Park IH; Yoon SS; Minami T; Korenberg JR; Folkman J; Daley GQ; Aird WC; Galdzicki Z; Ryeom S
Nature; 2009 Jun; 459(7250):1126-30. PubMed ID: 19458618
[TBL] [Abstract][Full Text] [Related]
4. Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth.
Ryeom S; Baek KH; Rioth MJ; Lynch RC; Zaslavsky A; Birsner A; Yoon SS; McKeon F
Cancer Cell; 2008 May; 13(5):420-31. PubMed ID: 18455125
[TBL] [Abstract][Full Text] [Related]
5. VEGF selectively induces Down syndrome critical region 1 gene expression in endothelial cells: a mechanism for feedback regulation of angiogenesis?
Yao YG; Duh EJ
Biochem Biophys Res Commun; 2004 Aug; 321(3):648-56. PubMed ID: 15358155
[TBL] [Abstract][Full Text] [Related]
6. Down syndrome candidate region 1 isoform 1 mediates angiogenesis through the calcineurin-NFAT pathway.
Qin L; Zhao D; Liu X; Nagy JA; Hoang MV; Brown LF; Dvorak HF; Zeng H
Mol Cancer Res; 2006 Nov; 4(11):811-20. PubMed ID: 17114339
[TBL] [Abstract][Full Text] [Related]
7. A novel transcriptional complex on the VE-cadherin promoter regulated the downregulation of VE-cadherin in the Down Syndrome Candidate Region 1 isoform 1L-mediated angiogenesis.
Hou S; Niu G; Liu X; Bourbon PM; Zhang D; Cui P; Zhao K; Zhao D; Zeng H
Microvasc Res; 2021 Nov; 138():104209. PubMed ID: 34146582
[TBL] [Abstract][Full Text] [Related]
8. Down syndrome candidate region 1-like 1 (DSCR1-L1) mimics the inhibitory effects of DSCR1 on calcineurin signaling in endothelial cells and inhibits angiogenesis.
Gollogly LK; Ryeom SW; Yoon SS
J Surg Res; 2007 Sep; 142(1):129-36. PubMed ID: 17610901
[TBL] [Abstract][Full Text] [Related]
9. Down Syndrome Candidate Region 1 Isoform 1L regulated tumor growth by targeting both angiogenesis and tumor cells.
Chen C; Cui P; Zhao K; Niu G; Hou S; Zhao D; Zeng H
Microvasc Res; 2022 Mar; 140():104305. PubMed ID: 34958805
[TBL] [Abstract][Full Text] [Related]
10. Down syndrome critical region 1 positively correlates with angiogenesis in hypopharyngeal cancer.
Lv C; Liu D; Wei X
Mol Med Rep; 2017 Jan; 15(1):263-270. PubMed ID: 27922696
[TBL] [Abstract][Full Text] [Related]
11. Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome.
Reynolds LE; Watson AR; Baker M; Jones TA; D'Amico G; Robinson SD; Joffre C; Garrido-Urbani S; Rodriguez-Manzaneque JC; Martino-Echarri E; Aurrand-Lions M; Sheer D; Dagna-Bricarelli F; Nizetic D; McCabe CJ; Turnell AS; Kermorgant S; Imhof BA; Adams R; Fisher EM; Tybulewicz VL; Hart IR; Hodivala-Dilke KM
Nature; 2010 Jun; 465(7299):813-7. PubMed ID: 20535211
[TBL] [Abstract][Full Text] [Related]
12. DSCR1 gene expression is dependent on NFATc1 during cardiac valve formation and colocalizes with anomalous organ development in trisomy 16 mice.
Lange AW; Molkentin JD; Yutzey KE
Dev Biol; 2004 Feb; 266(2):346-60. PubMed ID: 14738882
[TBL] [Abstract][Full Text] [Related]
13. Association of metastin/a G-protein-coupled receptor signaling and Down syndrome critical region 1 in epithelial ovarian cancer.
Hata K; Watanabe Y; Nakai H; Minami T; Ohsaki H; Hirakawa E; Hoshiai H
Anticancer Res; 2009 Feb; 29(2):617-23. PubMed ID: 19331211
[TBL] [Abstract][Full Text] [Related]
14. Arsenic Trioxide Restrains Lung Cancer Growth and Metastasis by Blocking the Calcineurin-NFAT Pathway by Upregulating DSCR1.
Yang MH; Wang YS; Shi XQ; Zhao XW; Li B
Curr Cancer Drug Targets; 2022; 22(10):854-864. PubMed ID: 35770414
[TBL] [Abstract][Full Text] [Related]
15. A single extra copy of Down syndrome critical region 1-4 results in impaired hepatic glucose homeostasis.
Seo DS; Chau GC; Baek KH; Um SH
Mol Metab; 2019 Mar; 21():82-89. PubMed ID: 30583978
[TBL] [Abstract][Full Text] [Related]
16. Restoration of DSCR1 to disomy in the trisomy 16 mouse model of Down syndrome does not correct cardiac or craniofacial development anomalies.
Lange AW; Rothermel BA; Yutzey KE
Dev Dyn; 2005 Jul; 233(3):954-63. PubMed ID: 15906378
[TBL] [Abstract][Full Text] [Related]
17. DSCR1 (ADAPT78) lethality: evidence for a protective effect of trisomy 21 genes?
Kluetzman KS; Perez AV; Crawford DR
Biochem Biophys Res Commun; 2005 Nov; 337(2):595-601. PubMed ID: 16198305
[TBL] [Abstract][Full Text] [Related]
18. IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: A potential anti-angiogenic therapeutic target.
Carneiro-Lobo TC; Scalabrini LC; Magalhães LDS; Cardeal LB; Rodrigues FS; Dos Santos EO; Baldwin AS; Levantini E; Giordano RJ; Bassères DS
Lung Cancer; 2019 Apr; 130():169-178. PubMed ID: 30885340
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of DSCR1 (RCAN1 or Adapt78) in the peri-infarct cortex after experimental stroke.
Cho KO; Kim YS; Cho YJ; Kim SY
Exp Neurol; 2008 Jul; 212(1):85-92. PubMed ID: 18485347
[TBL] [Abstract][Full Text] [Related]
20. Raf-1 is a binding partner of DSCR1.
Cho YJ; Abe M; Kim SY; Sato Y
Arch Biochem Biophys; 2005 Jul; 439(1):121-8. PubMed ID: 15935327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
